Dry Macular Degeneration May Be Treated by Anti-Placental Growth Factor Antibody, Aflibercept
Aflibercept is currently a treatment for wet Age-Related Macular Degeneration (AMD), but it may also prove useful for patients with dry AMD. The researchers accidentally discovered that an anti-placental growth factor antibody could provide retinal protection for the dry form of Macular Degeneration. They tried using a known protein called placental growth factor (PlGF) on … Continue reading “Dry Macular Degeneration May Be Treated by Anti-Placental Growth Factor Antibody, Aflibercept”